Microbot Medical Inc. has been granted several new patents across the U.S., Japan, China, and Canada, increasing its total to 44 issued patents and 49 pending globally. This strengthens the company's intellectual property portfolio as it expands commercialization of its LIBERTY® Endovascular Robotic System in the U.S. and prepares for growth in international markets, including pursuing a CE Mark for the EU. The LIBERTY system is the only FDA-cleared, single-use robotic device for peripheral endovascular procedures, designed to improve precision and safety. The company views its robust patent estate as critical for supporting market expansion and monetizing its innovative technology.
Microbot Medical's expanding patent portfolio is notable amid today's Health-sector trading on Pluang. For readers following Health-sector US stocks, here is Pluang's market snapshot as of Oct 20, 2026 19:03 WIB: out of 150 priced stocks, 81 rose and 62 fell. XRAY (DENTSPLY SIRONA Inc) gained 4.99% to USD 8.84 with a typical hold time of 73 days, while ENVB (Enveric Biosciences Inc) dropped 4.96% to USD 1.34 with 100% sell order activity and a 14-day hold time. MMED (MiniMed Group Inc. Common Stock) declined 3.49% to USD 17.17 with a typical hold time of 11 days.
Hershey is preparing to announce its Q3 earnings on October 29, with analysts forecasting earnings per share (EPS) of $2.12, a 63% increase from last year, and revenue of $3.25 billion, up 2.3%. The company has shown strong recent performance, with Q...
3M reported strong Q3 2026 earnings with adjusted EPS of $2.50, beating estimates of $2.38, and GAAP profit rising to $1.37 billion from $834 million a year earlier. Sales reached $6.6 billion, slightly below estimates, but showed 3.3% organic growth...
Alaska Air Group is set to report Q3 2026 earnings with analysts expecting a 66.7% drop in earnings per share to $0.35, despite a 14.5% increase in revenue to $4.31 billion driven by strong travel demand. Passenger revenue is forecast to rise 10.2%, ...
Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its ...
Richard Campbell-Breeden, a seasoned investment banker with 37 years of experience including 27 years at Goldman Sachs, has joined SEDA Experts LLC as Managing Director. His expertise in mergers and acquisitions, corporate finance, and governance wil...
